Next quarter’s earnings estimate for CYCC is -$0.29 with a range of -$0.29 to -$0.29. The previous quarter’s EPS was -$0.18. CYCC beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.06% of the time in the same period. In the last calendar year CYCC has Outperformed its overall industry.

CYCC Sales Forecast

Next quarter’s sales forecast for CYCC is $10.00K with a range of $10.00K to $10.00K. The previous quarter’s sales results were $10.00K. CYCC beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 46.67% of the time in the same period. In the last calendar year CYCC has Outperformed its overall industry.

Detailed List of Analyst Forecasts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Jonathan Aschoff

Roth MKM

―

Hold

―

Downgraded

10/23/24

Cyclacel Pharmaceuticals downgraded to Neutral from Buy at Roth MKMCyclacel Pharmaceuticals downgraded to Neutral from Buy at Roth MKM

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Cyclacel Pharmaceuticals

Currently, no data available

Please return soon. This page is being updated.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

CYCC Analyst Recommendation Trends

Rating

Nov 23

Dec 23

Jun 24

Aug 24

Oct 24

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, CYCC has received 2 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. CYCC average Analyst price target in the past 3 months is ―.

Each month's total comprises the sum of three months' worth of ratings.

CYCC Stock Forecast FAQ

What is CYCC’s average 12-month price target, according to analysts?

Currently, no data Available

What is CYCC’s upside potential, based on the analysts’ average price target?

Currently there's no upside potential for CYCC, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is CYCC a Buy, Sell or Hold?

Cyclacel Pharmaceuticals has a consensus rating of Hold which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.

What is Cyclacel Pharmaceuticals’s price target?

Currently, no data Available

What do analysts say about Cyclacel Pharmaceuticals?

Cyclacel Pharmaceuticals’s analyst rating consensus is a Hold. This is based on the ratings of 0 Wall Streets Analysts.

How can I buy shares of CYCC?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Cyclacel Pharmaceuticals (CYCC) Stock Forecast & Price Target

CYCC Financial Forecast

CYCC Earnings Forecast